Crossmark

Anatomy-driven segmentation of parafoveal optical coherence tomography (OCT) measures may improve associations with clinical outcomes in multiple sclerosis

Crossref DOI link: https://doi.org/10.1007/s00415-024-12866-4

Published Online: 2025-01-15

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mirmosayyeb, Omid

Weinstock-Guttman, Bianca

Zivadinov, Robert

Jakimovski, Dejan https://orcid.org/0000-0001-7114-4958
License Information

Text and Data Mining valid from 2025-01-15

Version of Record valid from 2025-01-15
More Information

Article History

Received: 9 August 2024

Revised: 11 December 2024

Accepted: 15 December 2024

First Online: 15 January 2025

Declarations

:

: Omid Mirmosayyeb and Dejan Jakimovski have nothing to disclose. Bianca Weinstock-Guttman received honoraria as a speaker and/or as a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme, Sanofi, Genentech, Novartis, Celgene/BMS, Janssen and Horizon Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genzyme, Genentech, Sanofi, Novartis. Robert Zivadinov has received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Protembis, Janssen, 415 Capital, and Novartis for speaking and consultant fees. He received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, CorEvitas, Protembis and V-WAVE Medical.

Document is current

Any future updates will be listed below